Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-09
1996-05-28
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514385, 514396, A01N 4364, A61K 3141, C07D24914, C07D23300
Patent
active
055212034
ABSTRACT:
A compound for treating a patient having a solid tumor in which it is known or suspected that hypoxic cells are present, which is a compound of formula (A): ##STR1## wherein X represents a nitro-substituted aromatic or hetero-aromatic group with a one-electron reduction potential at pH 7 of from -250 to -500 mV; each of R'.sub.1 to R'.sub.5 independently represents hydrogen or an alkyl, hydroxyalkyl, aryl, aralkyl or alkaryl group; m is 0 or 1; n is 1 or 2; and Z' represents a leaving group which has the potential for expulsion via an intramolecular cyclization reaction; or a physiologically acceptable acid addition salt thereof.
REFERENCES:
patent: 4113953 (1978-09-01), Cavalleri et al.
patent: 4241060 (1980-12-01), Smithen
patent: 4282232 (1981-08-01), Agrawal et al.
patent: 4371540 (1983-02-01), Lee et al.
patent: 4462992 (1984-07-01), Agrawal
patent: 4581368 (1986-04-01), Ahmed et al.
patent: 4596817 (1986-06-01), Ahmed et al.
patent: 4631289 (1986-12-01), Ahmed et al.
patent: 4757148 (1988-07-01), Ahmed et al.
patent: 4797397 (1989-01-01), Suto et al.
patent: 4900825 (1990-02-01), Koehler et al.
patent: 4954515 (1990-09-01), Suto
patent: 4999364 (1991-03-01), Boyle et al.
patent: 5051439 (1991-09-01), Schermanz et al.
patent: 5073639 (1991-12-01), Suto
Chem. Abstr. vol. 40, Entry 19822d (1989).
Merck Index, 10th Ed. 1983 1983 entry 6033.
Chem. Abstr. vol 105 entry 186743j (1986).
Chem. Abstr. vol. 105 entry 1864745m (1986).
Chem. Abstr. vol. 109 entry 50917u (1988).
J. Med. Chem. 1987, vol. 30 No. 11, p. 2092.
Kano et al, Tetrahedron Letters, pp. 6331-6334, vol. 28 No. 50 (1987).
Evans et al, J. Am. Chem. Soc. pp. 2127-2129, vol. 103 (1981).
Ishizuka and Kunieda, Tetrahedron Letters, pp. 4185-4188, vol. 28 No. 36 (1987).
Kleschick et al, J. Org. Chem., pp. 3168-3169, vol. 52 No. 14 (1987).
J. Med. Chem., pp. 55-59, vol. 31 No. 1 (1988).
Chem. Abstr., 102:6544 (1985).
J. Am. Chem. Soc., pp. 6395-6397, vol. 108 (1986).
Hayashi et al, Tetrahedron Letters, vol. 29 No. 1, pp. 99-102 (1988).
T. C. Jenkins et al "Synthesis and evaluation . . . " J. Med. Chem. 1990, 33, pp. 2603-2610.
S. Cole et al, "Dual-function 2-Nitroimidazoles . . . " Radiation Research, 124 (1990) pp. 538-543.
S. Cole et al "Oral (po) dosing with RSU . . . " Int. J. Oncology Biol. Phys., vol. 21, pp. 387-395 (1991).
S. Cole et al "Dual function nitroimidazoles . . . " Int. J. Radiation Oncology Biol. Phys., vol. 22, pp. 545-548 (1990).
J. S. Sebolt-Leopold et al. "Pharmacologic/pharmacokinetic . . . " Int. J. Radition Oncology Biol. Phys., vol. 22, pp. 549-551 (1991).
Adams Gerald E.
Fielden Edward M.
Jenkins Terence C.
Stratford Ian J.
British Technology Group Limited
Nutter Nathan M.
LandOfFree
Nitro-substituted aromatic or hetero-aromatic compounds for use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitro-substituted aromatic or hetero-aromatic compounds for use , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitro-substituted aromatic or hetero-aromatic compounds for use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-787205